182 related articles for article (PubMed ID: 7626010)
1. Structural and functional properties of heparin analogues obtained by chemical sulphation of Escherichia coli K5 capsular polysaccharide.
Razi N; Feyzi E; Björk I; Naggi A; Casu B; Lindahl U
Biochem J; 1995 Jul; 309 ( Pt 2)(Pt 2):465-72. PubMed ID: 7626010
[TBL] [Abstract][Full Text] [Related]
2. Biosynthesis of heparin. Use of Escherichia coli K5 capsular polysaccharide as a model substrate in enzymic polymer-modification reactions.
Kusche M; Hannesson HH; Lindahl U
Biochem J; 1991 Apr; 275 ( Pt 1)(Pt 1):151-8. PubMed ID: 1902083
[TBL] [Abstract][Full Text] [Related]
3. Heparin-like compounds prepared by chemical modification of capsular polysaccharide from E. coli K5.
Casu B; Grazioli G; Razi N; Guerrini M; Naggi A; Torri G; Oreste P; Tursi F; Zoppetti G; Lindahl U
Carbohydr Res; 1994 Oct; 263(2):271-84. PubMed ID: 7805054
[TBL] [Abstract][Full Text] [Related]
4. Generation of "neoheparin" from E. coli K5 capsular polysaccharide.
Lindahl U; Li JP; Kusche-Gullberg M; Salmivirta M; Alaranta S; Veromaa T; Emeis J; Roberts I; Taylor C; Oreste P; Zoppetti G; Naggi A; Torri G; Casu B
J Med Chem; 2005 Jan; 48(2):349-52. PubMed ID: 15658847
[TBL] [Abstract][Full Text] [Related]
5. Biosynthesis of heparin. Enzymatic sulfation of pentasaccharides.
Kusche M; Oscarsson LG; Reynertson R; Rodén L; Lindahl U
J Biol Chem; 1991 Apr; 266(12):7400-9. PubMed ID: 1902219
[TBL] [Abstract][Full Text] [Related]
6. Structure and antithrombin-binding properties of heparin isolated from the clams Anomalocardia brasiliana and Tivela mactroides.
Pejler G; Danielsson A; Björk I; Lindahl U; Nader HB; Dietrich CP
J Biol Chem; 1987 Aug; 262(24):11413-21. PubMed ID: 3624220
[TBL] [Abstract][Full Text] [Related]
7. Substrate specificities of glycosyltransferases involved in formation of heparin precursor and E. coli K5 capsular polysaccharides.
Lidholt K; Fjelstad M; Jann K; Lindahl U
Carbohydr Res; 1994 Mar; 255():87-101. PubMed ID: 8181017
[TBL] [Abstract][Full Text] [Related]
8. Toward a biotechnological heparin through combined chemical and enzymatic modification of the Escherichia coli K5 polysaccharide.
Naggi A; Torri G; Casu B; Oreste P; Zoppetti G; Li JP; Lindahl U
Semin Thromb Hemost; 2001 Oct; 27(5):437-43. PubMed ID: 11668413
[TBL] [Abstract][Full Text] [Related]
9. New insights on the specificity of heparin and heparan sulfate lyases from Flavobacterium heparinum revealed by the use of synthetic derivatives of K5 polysaccharide from E. coli and 2-O-desulfated heparin.
Nader HB; Kobayashi EY; Chavante SF; Tersariol IL; Castro RA; Shinjo SK; Naggi A; Torri G; Casu B; Dietrich CP
Glycoconj J; 1999 Jun; 16(6):265-70. PubMed ID: 10579695
[TBL] [Abstract][Full Text] [Related]
10. Biosynthesis of heparin. The D-glucuronosyl- and N-acetyl-D-glucosaminyltransferase reactions and their relation to polymer modification.
Lidholt K; Lindahl U
Biochem J; 1992 Oct; 287 ( Pt 1)(Pt 1):21-9. PubMed ID: 1417774
[TBL] [Abstract][Full Text] [Related]
11. Biosynthesis of heparin. O-sulfation of the antithrombin-binding region.
Kusche M; Bäckström G; Riesenfeld J; Petitou M; Choay J; Lindahl U
J Biol Chem; 1988 Oct; 263(30):15474-84. PubMed ID: 3139669
[TBL] [Abstract][Full Text] [Related]
12. Structure of the Escherichia coli 0104 polysaccharide and its identity with the capsular K9 polysaccharide.
Kogan G; Jann B; Jann K
FEMS Microbiol Lett; 1992 Mar; 70(2):135-40. PubMed ID: 1587460
[TBL] [Abstract][Full Text] [Related]
13. Assignment of the 1H-n.m.r. spectra of heparin and heparan sulphate.
Mulloy B; Johnson EA
Carbohydr Res; 1987 Dec; 170(2):151-65. PubMed ID: 2963692
[TBL] [Abstract][Full Text] [Related]
14. Identification of O-sulphate substituents on D-glucuronic acid units in heparin-related glycosaminoglycans using novel synthetic disaccharide standards.
Razi N; Kreuger J; Lay L; Russo G; Panza L; Lindahl B; Lindahl U
Glycobiology; 1995 Dec; 5(8):807-11. PubMed ID: 8720079
[TBL] [Abstract][Full Text] [Related]
15. Biosynthesis of heparin. Availability of glucosaminyl 3-O-sulfation sites.
Kusche M; Torri G; Casu B; Lindahl U
J Biol Chem; 1990 May; 265(13):7292-300. PubMed ID: 2332430
[TBL] [Abstract][Full Text] [Related]
16. Dynamic properties of biologically active synthetic heparin-like hexasaccharides.
Angulo J; Hricovíni M; Gairi M; Guerrini M; de Paz JL; Ojeda R; Martín-Lomas M; Nieto PM
Glycobiology; 2005 Oct; 15(10):1008-15. PubMed ID: 15958415
[TBL] [Abstract][Full Text] [Related]
17. Location of antithrombin-binding regions in rat skin heparin proteoglycans.
Jacobsson KG; Lindahl U; Horner AA
Biochem J; 1986 Dec; 240(3):625-32. PubMed ID: 3827857
[TBL] [Abstract][Full Text] [Related]
18. Low-sulphated oligosaccharides derived from heparan sulphate inhibit normal angiogenesis.
Hahnenberger R; Jakobson AM; Ansari A; Wehler T; Svahn CM; Lindahl U
Glycobiology; 1993 Dec; 3(6):567-73. PubMed ID: 7510546
[TBL] [Abstract][Full Text] [Related]
19. Biosynthesis of the escherichia coli K4 capsule polysaccharide. A parallel system for studies of glycosyltransferases in chondroitin formation.
Lidholt K; Fjelstad M
J Biol Chem; 1997 Jan; 272(5):2682-7. PubMed ID: 9006904
[TBL] [Abstract][Full Text] [Related]
20. Heparin proteoglycans synthesized by mouse mastocytoma contain chondroitin sulphate.
Lidholt K; Eriksson I; Kjellén L
Biochem J; 1995 Oct; 311 ( Pt 1)(Pt 1):233-8. PubMed ID: 7575459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
